The Ministry of Health has updated its findings in the ongoing investigation into infant purees produced under the “Prinok” brand, confirming the discovery of two additional products containing sedative substances.
According to the latest statement released last week, the newly identified items contained traces of benzodiazepines—specifically Clonazepam and Lorazepam—bringing the total number of contaminated products to five.
How the Contaminated Products Were Discovered
Authorities explained that the investigation combined samples submitted by affected families with products collected directly from retail shelves in Jerusalem.
Three of the contaminated jars were handed over by parents whose children had already been hospitalized after consuming the puree.
The remaining two were obtained by inspectors during in-store sampling at a food chain branch in the city.
Officials say the widening scope of the findings suggests that multiple batches of the product may have been affected.
Hospital Cases Raise Early Warning Signs
To date, two separate incidents have been recorded involving five children who were hospitalized after suspected exposure to benzodiazepines, a class of psychoactive drugs typically used for anxiety relief and sleep disorders.
The first warning signs reportedly emerged about a month earlier, when two children were admitted to Hadassah Ein Kerem Hospital after exhibiting similar symptoms.
Medical staff sent a sample of the consumed puree—purchased at a local supermarket—to police, who then requested laboratory testing from health authorities.
Concerns Over Delayed Testing Response
Questions have since emerged regarding the Ministry of Health’s response in the early stages of the investigation.
Despite receiving the initial sample through police channels, the ministry did not immediately conduct testing on the suspected product.
It was only after a second incident occurred—when three additional children were rushed to hospital on the same day—that authorities formally requested the original jar for analysis.
This delay has raised concerns among observers about whether earlier intervention could have prevented additional exposure cases.
Legal Scrutiny Over Possible Regulatory Negligence
The unfolding case has prompted debate over whether the Ministry of Health could face legal responsibility for its handling of the incident.
Attorney Assaf Warsha, a specialist in tort law, explained that negligence claims typically rely on four legal elements: duty of care, breach of duty, damage, and causation.
In this case, he argued, the first two elements appear potentially relevant given the ministry’s mandate to oversee food safety and respond to credible health risks.
He noted that once a specific product linked to hospitalizations was identified, a reasonable regulator would be expected to immediately initiate laboratory testing to prevent further harm.
Parents May Be Considered Indirect Victims
Although the affected children were discharged after treatment and are not reported to have suffered lasting physical harm, legal experts suggest that the psychological impact on parents may be significant.
Under tort law principles, parents may be classified as indirect victims if they meet certain conditions, including close familial relationship, direct exposure to the incident, and demonstrable psychological injury.
Whether these experiences meet the legal threshold for compensation remains subject to medical and judicial assessment.
Psychological Trauma Beyond Physical Recovery
From a psychological standpoint, experts note that traumatic reactions among parents are often driven by the experience itself rather than the severity of physical injury.
Reactions such as intrusive memories, anxiety, sleep disruption, and heightened alertness are commonly associated with pediatric medical trauma.
In some cases, these symptoms may develop into long-term post-traumatic stress disorder.
Specialists emphasize that even when children recover quickly, parents who witness sudden medical emergencies may remain emotionally affected for extended periods.
Possible Compensation Ranges Under Review
Should claims proceed, compensation levels would likely depend on the severity and duration of psychological harm.
Temporary distress cases without lasting disability could result in awards in the tens of thousands of shekels, mainly covering emotional suffering and treatment costs.
More severe cases involving long-term psychological impairment could reach significantly higher sums, potentially extending into hundreds of thousands of shekels depending on individual circumstances.
How Similar Cases Are Treated in the United States
Legal experts also point to a contrasting framework in the United States, where government liability is shaped by sovereign immunity laws.
Under this doctrine, public agencies are generally protected from punitive damages, even in cases involving negligence.
As a result, plaintiffs may only recover compensation for proven direct harm, rather than additional punitive awards intended to punish wrongdoing.
This creates a legal paradox, where state bodies may be shielded from the kind of penalties often associated with corporate misconduct cases, despite the severity of public impact.
- Shakes Mashaba’s Shocking Health Crisis: Cancer, TB and a R100,000 Medical Bill Nightmare Exposed
- UK Resident Doctors to Vote on Government Pay and Training Reform Deal
- Chocolate Is Healthy” Claim Sparks Debate — But Only If You Eat THIS Type, Doctor Warns
- Ebola Outbreak in DRC Triggers Alarm as Government Confirms Rising Death Toll to 101 While Armed Groups Disrupt Life-Saving Response Operations Across Ituri, North Kivu and South Kivu Provinces
- John Fashanu Publicly Blasts Daughter Amal Fashanu in Explosive Health Denial Clash as Family Feud Erupts in Lagos Over Mystery Illness Claims
- Woman In Britain Risks Health Debate As She Considers Switching From Mounjaro In UK Weight Loss Dilemma Over Unlicensed “Godzilla Jab” Retatrutide Alternative